CDK-TCIP2
Product Specifications
Target
Bcl-6, CDK
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint
Bioactivity
DK-TCIP2 is an anticancer agent formed by linking the CDK9 inhibitor SNS-032 and the BCL6 inhibitor BI-3812. This compound exhibits anticancer activity both in vivo and in vitro, making it suitable for research in lymphoma.
Smiles
C(F)(F)(F)C1=C2C(CN(C[C@H]3C[C@@H](C(F)(F)F)CCC3)C2=O)=NC(N)=N1
Molecular Formula
C52H67ClN12O8S2
Molecular Weight
1087.75
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A05384-1-Dylight550 100 µg
Anti-HES5 Antibody Picoband®, Dylight550 Conjugate
Sign In for Pricing
View Details 
032115-ML490 100 µL
ASAH2, CT (ASAH2, HNAC1, Neutral ceramidase, Acylsphingosine deacylase 2, BCDase, LCDase, N-acylsphingosine amidohydrolase 2, Non-lysosomal ceramidase, Neutral ceramidase soluble form) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
H9463 96 Tests
Tumor Necrosis Factor Receptor Superfamily (member 1A (TNFRSF1A) Rat ELISA Kit
Sign In for Pricing
View Details